Cargando…
Akt: A Potential Drug Target for Metabolic Syndrome
The serine/threonine kinase Akt, also known as protein kinase B (PKB), is one of the key factors regulating glucose and lipid energy metabolism, and is the core focus of current research on diabetes and metabolic diseases. Akt is mostly expressed in key metabolism-related organs and it is activated...
Autores principales: | Miao, Runyu, Fang, Xinyi, Wei, Jiahua, Wu, Haoran, Wang, Xinmiao, Tian, Jiaxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940245/ https://www.ncbi.nlm.nih.gov/pubmed/35330934 http://dx.doi.org/10.3389/fphys.2022.822333 |
Ejemplares similares
-
Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
por: Fang, Xinyi, et al.
Publicado: (2022) -
Advances in multi-omics study of biomarkers of glycolipid metabolism disorder
por: Fang, Xinyi, et al.
Publicado: (2022) -
Research progress on the pharmacological effects of berberine targeting mitochondria
por: Fang, Xinyi, et al.
Publicado: (2022) -
PDX-1: A Promising Therapeutic Target to Reverse Diabetes
por: Zhang, Yanjiao, et al.
Publicado: (2022) -
Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities
por: Miao, Runyu, et al.
Publicado: (2023)